CGT-0292

N/A

Report date: 2025/01/26 16:47:09
NME

Base Information

Drug NameCGT-0292
Drug Alias NameFGFR2 antagonist (Cogent Biosciences)CGT-0292
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 2 antagonists
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A